Both Retatrutide and Semaglutide represent exciting advancements in diabetes care, but they function through slightly different mechanisms. Semaglutide primarily targets GLP-1 receptors, stimulating insulin https://margiegoqi832603.daneblogger.com/40459788/novoretatrutide-vs-copyright-a-head-to-head-assessment